Christopher R Brown, MD
Pulmonary Disease · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 44 years
- Northwestern University Feinberg Medical School, 1982
Offices
2 locations · San Francisco Critical Care Med Group Inc · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brown’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G50990 · Current
Licensed to practise in California · since 1983 · expires 2026-10-31 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$77,977
Medicare paid this office $77,977 for 199 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 134 | $61,078 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,416 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,444 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,257 | $71 |
| Test to examine how well the lungs exchange gases | 11 | $90 | $8 |
Who their Medicare patients are
199 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 13% · Women 45% · Also on Medicaid 59% · Health risk score 2.82. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 52% · Chronic kidney disease 48% · Heart failure 46% · Coronary heart disease 45% · Atrial fibrillation 38% · COPD 36% · Depression 34% · Stroke 31% · Cancer 23% · Dementia 23%.
The office billed $199,276, Medicare allowed $97,789 and paid $77,977; for 511 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 199 | 511 | 72 | 2.82 | $199,276 | $77,977 |
| 2023 | 167 | 441 | 74 | 2.80 | $180,959 | $68,345 |
| 2022 | 199 | 682 | 75 | 2.50 | $233,592 | $88,344 |
| 2021 | 257 | 954 | 73 | 2.41 | $281,523 | $108,932 |
| 2020 | 227 | 803 | 73 | 2.47 | $245,648 | $97,610 |
| 2019 | 228 | 656 | 73 | 2.75 | $203,901 | $77,889 |
| 2018 | 214 | 637 | 73 | 2.64 | $207,310 | $79,636 |
| 2017 | 236 | 700 | 74 | 2.48 | $244,053 | $94,625 |
| 2016 | 295 | 851 | 72 | 2.78 | $319,889 | $124,861 |
| 2015 | 263 | 700 | 74 | 2.44 | $244,590 | $96,100 |
| 2014 | 265 | 698 | 71 | 2.33 | $239,102 | $93,324 |
| 2013 | 342 | 856 | 73 | 2.49 | $262,209 | $101,722 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Critical care, first 30-74 minutes | 115 | $52,707 | $186 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,515 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,559 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,444 | $68 |
2022: 4 services
| Critical care, first 30-74 minutes | 121 | $57,002 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $16,229 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $6,656 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,917 | $176 |
2021: 7 services
| Critical care, first 30-74 minutes | 117 | $65,010 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $25,861 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,494 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $5,307 | $63 |
| Test to determine lung volumes using sensors | 53 | $578 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 48 | $448 | $9 |
| Test to examine how well the lungs exchange gases | 54 | $435 | $8 |
2020: 7 services
| Critical care, first 30-74 minutes | 99 | $53,670 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $29,309 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,718 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,101 | $66 |
| Test to determine lung volumes using sensors | 28 | $318 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $313 | $12 |
| Test to examine how well the lungs exchange gases | 29 | $243 | $8 |
2019: 7 services
| Critical care, first 30-74 minutes | 116 | $41,378 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $18,210 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $6,442 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,234 | $178 |
| Test to determine lung volumes using sensors | 13 | $143 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 12 | $140 | $12 |
| Test to examine how well the lungs exchange gases | 13 | $106 | $8 |
2018: 9 services
| Critical care, first 30-74 minutes | 108 | $48,386 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $9,439 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $8,999 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,877 | $178 |
| Return visit (30+ min) | 13 | $1,639 | $91 |
| Short return visit (20+ min) | 16 | $1,436 | $65 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 11 | $117 | $11 |
| Test to determine lung volumes using sensors | 11 | $110 | $10 |
| Test to examine how well the lungs exchange gases | 12 | $89 | $7 |
2017: 9 services
| Critical care, first 30-74 minutes | 131 | $69,984 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $5,037 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,911 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,522 | $181 |
| Short return visit (20+ min) | 24 | $1,983 | $58 |
| Return visit (30+ min) | 15 | $1,750 | $92 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $258 | $10 |
| Test to determine lung volumes using sensors | 25 | $254 | $10 |
| Test to examine how well the lungs exchange gases | 25 | $191 | $8 |
2016: 11 services
| Critical care, first 30-74 minutes | 171 | $95,955 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $8,198 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,987 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,493 | $65 |
| Short return visit (20+ min) | 31 | $2,470 | $62 |
| Return visit (30+ min) | 15 | $2,041 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,424 | $119 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,147 | $96 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $223 | $11 |
| Test to determine lung volumes using sensors | 21 | $211 | $10 |
| Test to examine how well the lungs exchange gases | 19 | $140 | $7 |
2015: 10 services
| Critical care, first 30-74 minutes | 137 | $64,611 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,190 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $6,177 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $5,601 | $65 |
| Return visit (30+ min) | 25 | $3,382 | $102 |
| Short return visit (20+ min) | 24 | $2,237 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,210 | $123 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $177 | $11 |
| Test to determine lung volumes using sensors | 15 | $156 | $10 |
| Test to examine how well the lungs exchange gases | 16 | $123 | $8 |
2014: 10 services
| Critical care, first 30-74 minutes | 131 | $67,840 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $5,569 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,155 | $181 |
| Return visit (30+ min) | 25 | $2,785 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,701 | $63 |
| Short return visit (20+ min) | 25 | $1,981 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,589 | $122 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 30 | $365 | $12 |
| Test to determine lung volumes using sensors | 30 | $332 | $11 |
| Test to examine how well the lungs exchange gases | 29 | $238 | $8 |
2013: 11 services
| Critical care, first 30-74 minutes | 137 | $59,052 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $8,650 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $8,128 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,134 | $175 |
| Return visit (30+ min) | 36 | $4,668 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,923 | $119 |
| Short return visit (20+ min) | 25 | $1,834 | $63 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,246 | $104 |
| Test to determine lung volumes using sensors | 25 | $278 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $231 | $11 |
| Test to examine how well the lungs exchange gases | 25 | $204 | $8 |
Medicaid work
$43,181 in 2024
Medicaid paid $43,181 for 286 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 286 | $43,181 |
| 2024 | 286 | 1 | 20 | $43,181 |
| 2023 | 381 | 1 | 20 | $73,631 |
| 2022 | 157 | 1 | 16 | $24,163 |
| 2021 | 294 | 1 | 22 | $48,109 |
| 2020 | 75 | 2 | 12 | $2,986 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 381 | $73,631 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 157 | $24,163 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 294 | $48,109 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 40 | $2,099 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $886 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 35 Part D prescriptions in 2021. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2021 | 35 | None | 0% (0) | 66% | $14,958 |
| 2020 | 133 | 19 | 0% (0) | 66% | $71,578 |
| 2019 | 225 | 24 | None | 67% | $103,335 |
| 2018 | 254 | 31 | 0% (0) | 59% | $90,581 |
| 2017 | 273 | 29 | None | 64% | $104,060 |
| 2016 | 361 | 37 | 4% (15) | 62% | $200,089 |
| 2015 | 366 | 40 | 8% (29) | 52% | $167,539 |
| 2014 | 468 | 53 | 8% (36) | 48% | $213,794 |
| 2013 | 517 | 60 | 7% (36) | 48% | $190,799 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Symbicort | 11 | $7,327 | $666 |
2020: 3 drugs
| Symbicort | 31 | $14,364 | $463 |
| Spiriva | 11 | $5,926 | $539 |
| Prednisone | 18 | $64 | $4 |
2019: 8 drugs
| Creon | 11 | $44,899 | $4,082 |
| Symbicort | 29 | $13,301 | $459 |
| Spiriva | 24 | $10,147 | $423 |
| Combivent Respimat | 11 | $6,478 | $589 |
| Ventolin Hfa | 16 | $1,625 | $102 |
| Proair Hfa | 17 | $1,120 | $66 |
| Promethazine | 12 | $193 | $16 |
| Montelukast | 18 | $155 | $9 |
2018: 10 drugs
| Symbicort | 32 | $13,218 | $413 |
| Spiriva | 31 | $12,396 | $400 |
| Advair Diskus | 18 | $9,525 | $529 |
| Combivent Respimat | 13 | $6,043 | $465 |
| Ventolin Hfa | 14 | $1,364 | $97 |
| Proair Hfa | 14 | $921 | $66 |
| Montelukast | 28 | $260 | $9 |
| Promethazine | 11 | $236 | $21 |
| Azithromycin | 17 | $188 | $11 |
| Prednisone | 11 | $80 | $7 |
2017: 10 drugs
| Creon | 12 | $38,431 | $3,203 |
| Advair Diskus | 24 | $15,206 | $634 |
| Spiriva | 37 | $13,670 | $369 |
| Symbicort | 32 | $9,801 | $306 |
| Combivent Respimat | 21 | $9,762 | $465 |
| Ventolin Hfa | 22 | $1,930 | $88 |
| Montelukast | 25 | $416 | $17 |
| Promethazine | 11 | $240 | $22 |
| Prednisone | 20 | $176 | $9 |
| Azithromycin | 14 | $119 | $8 |
2016: 10 drugs
| Creon | 12 | $40,935 | $3,411 |
| Advair Diskus | 29 | $17,575 | $606 |
| Spiriva | 49 | $16,594 | $339 |
| Combivent Respimat | 23 | $11,132 | $484 |
| Symbicort | 34 | $10,156 | $299 |
| Proair Hfa | 15 | $867 | $58 |
| Azithromycin | 22 | $866 | $39 |
| Montelukast | 20 | $241 | $12 |
| Promethazine | 13 | $163 | $13 |
| Prednisone | 13 | $109 | $8 |
2015: 9 drugs
| Creon | 13 | $41,877 | $3,221 |
| Spiriva | 51 | $16,673 | $327 |
| Advair Diskus | 18 | $11,097 | $616 |
| Combivent Respimat | 25 | $8,112 | $324 |
| Proair Hfa | 19 | $1,113 | $59 |
| Azithromycin | 27 | $888 | $33 |
| Montelukast | 16 | $262 | $16 |
| Temazepam | 11 | $212 | $19 |
| Diltiazem 24hr Cd | 12 | $194 | $16 |
2014: 13 drugs
| Cayston | 15 | $91,458 | $6,097 |
| Zenpep | 18 | $32,049 | $1,781 |
| Creon | 11 | $31,577 | $2,871 |
| Spiriva | 60 | $19,998 | $333 |
| Advair Diskus | 30 | $14,230 | $474 |
| Combivent Respimat | 20 | $6,257 | $313 |
| Dulera | 12 | $2,906 | $242 |
| Proair Hfa | 18 | $978 | $54 |
| Azithromycin | 23 | $961 | $42 |
| Montelukast | 17 | $415 | $24 |
| Prednisone | 40 | $300 | $8 |
| Tramadol | 11 | $127 | $12 |
| Metoprolol | 11 | $22 | $2 |
2013: 15 drugs
| Cayston | 13 | $74,362 | $5,720 |
| Creon | 12 | $29,224 | $2,435 |
| Zenpep | 15 | $23,508 | $1,567 |
| Advair Diskus | 55 | $22,121 | $402 |
| Spiriva | 68 | $20,915 | $308 |
| Combivent Respimat | 12 | $4,131 | $344 |
| Azithromycin | 24 | $1,191 | $50 |
| Montelukast | 21 | $1,090 | $52 |
| Proair Hfa | 17 | $794 | $47 |
| Proventil Hfa | 14 | $750 | $54 |
| Temazepam | 12 | $391 | $33 |
| Tramadol | 16 | $192 | $12 |
| Promethazine | 12 | $171 | $14 |
| Prednisone | 36 | $156 | $4 |
| Cyclobenzaprine | 12 | $96 | $8 |
Money from drug and device companies
$150 in 2024
| 2024 | 1 | 1 | None | $150 |
| 2023 | 1 | 1 | None | $17 |
| 2022 | 1 | 1 | None | $219 |
| 2021 | 2 | 7 | None | $189 |
| 2020 | 2 | 8 | None | $1,863 |
| 2019 | 4 | 4 | None | $90 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inari Medical | Flowtriever Catheter, S | $150 | 1 payment
|
See the published payment
| Inari Medical | Meals · 2024-06-25 | Flowtriever Catheter, S | $150 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $17
| Inari Medical | Flowtriever Catheter, S | $17 | 1 payment
|
2022: $219
| Inari Medical | Flowtriever Catheter, S | $219 | 1 payment
|
2021: $189
| Shockwave Medical | Vascular Lithotripsy | $103 | 1 payment
|
| Electromed | Smartvest | $86 | 6 payments
|
2020: $1,863
| Alphatec Spine | Other - Miscellaneous | $1,850 | 7 payments
|
| Merck Sharp & Dohme | Zerbaxa | $13 | 1 payment
|
2019: $90
| Teva Pharmaceuticals USA | Cinqair | $38 | 1 payment
|
| Mallinckrodt Enterprises | Ofirmev | $19 | 1 payment
|
| GlaxoSmithKline | Nucala | $19 | 1 payment
|
| Gilead Sciences | None | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1104900901
- Licence
- CA G50990California G50990: Current · expires 2026-10-31
- Trained
- Northwestern University Feinberg Medical School, 1982 · 44 years ago
- Group
- San Francisco Critical Care Med Group Inc · Sutter Bay Medical Foundation
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 2351 Clay St, 501, San Francisco, CA, 94115
- NPI first listed
- 2006-10-25
- NPI last updated
- 2007-07-11
This is when the NPI record was last certified, not a medical board exam.